GALT
Galectin Therapeutics
$3.38
−$0.09 (−2.59%)Jul 27, 2026
Key metrics
The numbers that frame GALT today
- Market cap
- $222.60M
- P/E (TTM)
- -8.5
- EV / FCF
- -17.2
- ROIC
- -21%
- Div yield
- 0%
- 52wk Low
- $2.03
- 52wk High
- $7.13
Growth
Revenue and earnings trend for GALT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about GALT
Is Galectin Therapeutics a good buy?
Hold. Galectin Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Galectin Therapeutics is selling at a high price.
What is the market capitalization of GALT?
Galectin Therapeutics's market capitalization is $222.60M.
What is the P/E ratio for GALT stock?
Galectin Therapeutics's current P/E ratio is -8.5.
What is the 52-week high for GALT stock?
The 52-week high for Galectin Therapeutics is $7.13. The current close of $3.38 is 52.6% below that high.
What is the 52-week low for GALT stock?
The 52-week low for Galectin Therapeutics is $2.03. The current close of $3.38 is 66.9% above that low.
Does GALT stock pay dividends?
Galectin Therapeutics does not currently show a dividend per share in the company data.